UPDATE : Friday, December 13, 2019
상단여백
Korean firms eyeing on growing orphan drug market by Jeong Sae-im 2019-08-14 14:48
‘Koreans don’t recognize suicidal signals well’ by Jeong Sae-im 2019-08-13 11:14
‘CPhI Korea thriving on local firms’ zeal for drug export’ by Jeong Sae-im 2019-08-08 14:54
[Reporter’s Notebook] SillaJen should be ashamed of itself by Jeong Sae-im 2019-08-07 13:59
HLB to seek pre-NDA meeting with FDA for rivoceranib by Jeong Sae-im 2019-08-06 15:43
라인
SillaJen remains confident about Pexa-Vec’s value, despite trial failure by Jeong Sae-im 2019-08-05 14:49
Suspicions resurge over SillaJen execs’ stock selling before Pexa-Vec trial suspension by Jeong Sae-im 2019-08-05 11:26
Biotech shares tank amid SillaJen’s likely halt of Pexa-Vec trial by Jeong Sae-im 2019-08-02 15:45
Eutilex pipelines are underrated: CEO by Jeong Sae-im 2019-08-01 16:08
Biotech industry group urges Japan to withdraw export curbs by Jeong Sae-im 2019-07-25 17:09
라인
[Focus] Korean biopharmas eye US Humira market by Jeong Sae-im 2019-07-25 15:02
Korean drugs strong in anti-reflux treatment market by Jeong Sae-im 2019-07-22 15:15
MedPacto passes tech assessment, seeks KOSDAQ listing this year by Jeong Sae-im 2019-07-19 17:01
Biopharmaceutical stocks face grim outlook in 2H by Jeong Sae-im 2019-07-17 14:11
Korean, Japanese healthcare firms reaffirm ‘joint growth’ amid trade feud by Jeong Sae-im 2019-07-17 14:06
라인
Government faces uphill battle to look into Medytox over illicit drug by Jeong Sae-im 2019-07-15 13:58
Doctors question Pexa-Vec+Imfinzi combo’s effect on colon cancer by Jeong Sae-im, Kim Yun-mi 2019-07-12 15:13
Court suspends decision on ministry’s order to revoke Invossa license by Jeong Sae-im 2019-07-12 13:11
Prosecutors raid 2 lead managers of Kolon TissueGene’s IPO by Jeong Sae-im 2019-07-11 16:39
NKMax America seeks NASDAQ listing by Jeong Sae-im 2019-07-11 12:41
여백
여백
여백
Back to Top